Technical Analysis for TRXPF - Torii Pharmaceutical

Grade Last Price % Change Price Change
grade C 23.5 -1.26% -0.3000
TRXPF closed down 1.26 percent on Monday, July 2, 2018, on 1.2 times normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent N/A N/A N/A
See historical TRXPF trend table...

Date Alert Name Type % Chg

Older signals for TRXPF ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Torii Pharmaceutical Co., Ltd. manufactures and markets pharmaceutical products. The company's products include REMITCH, an agent used for the treatment of pruritus in hemodialysis patients; Truvada, an antiretroviral agent used for the treatment of human immunodeficiency virus (HIV); ANTEBATE, an agent used for the treatment of skin diseases, such as atopic dermatitis and contact dermatitis by reducing inflammation; Riona, a therapeutic agent for hyperphosphatemia; and Stribild combination tablets for the treatment HIV. It also provides FUTHAN for injection, an anticoagulant drug used during hemodiafiltration; KAYEXALATE, a therapeutic agent for hyperkalemia treatment; and URINORM, an uricosuric agent. In addition, the company offers LOCOID, an agent used for the treatment of the inflammatory manifestations of dermatosis; and ZEFNART, a topical antifungal agent. Further, it provides CEDARTOLEN, a sublingual immunotherapy drug; MITICURE, an allergen immunotherapy tablet; Genvoya combination tablets for the treatment of HIV-1 infection; Descovy, an antiviral agent for HIV; Bio-Three viable bacterial preparations; URINORM, a renal diseases and hemodialysis uricosuric agent; and Magsent used for the treatment for premature labor Eclampsia-suppressing. Torii Pharmaceutical Co., Ltd. has collaboration with Japan Tobacco Inc. The company was formerly known as Torii Shoten K.K and changed its name to Torii Pharmaceutical Co., Ltd. in May 1949. The company was founded in 1872 and is headquartered in Tokyo, Japan. Torii Pharmaceutical Co., Ltd. is a subsidiary of Japan Tobacco Inc.
Chemistry Medicine RTT Pharmaceutical Products Organic Compounds Immunotherapy Inflammation Infection Hiv Atopic Dermatitis Hemodialysis Hepatotoxins Skin Diseases Allergen Immunotherapy Hyperphosphatemia Prevention Of Hiv/Aids Pruritus Gilead Sciences Hemodiafiltration Renal Diseases Treatment Of Hiv Treatment Of Skin Diseases
Is TRXPF a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 0 bearish and 5 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Indicators
Indicator Value
52 Week High 28.85
52 Week Low 23.5
Average Volume 166
200-Day Moving Average 0.0
50-Day Moving Average 0.0
20-Day Moving Average 0.0
10-Day Moving Average 0.0
Average True Range 0.0
ADX 0.0
+DI 0.0
-DI 0.0
Chandelier Exit (Long, 3 ATRs ) N/A
Chandelier Exit (Short, 3 ATRs ) N/A
Upper Bollinger Band 0.0
Lower Bollinger Band 0.0
Percent B (%b) 0.0
BandWidth 0.0
MACD Line 0.0
MACD Signal Line 0.0
MACD Histogram 0.0
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 23.5000
Resistance 3 (R3) 23.5000 23.5000 23.5000
Resistance 2 (R2) 23.5000 23.5000 23.5000 23.5000
Resistance 1 (R1) 23.5000 23.5000 23.5000 23.5000 23.5000
Pivot Point 23.5000 23.5000 23.5000 23.5000 23.5000
Support 1 (S1) 23.5000 23.5000 23.5000 23.5000 23.5000
Support 2 (S2) 23.5000 23.5000 23.5000 23.5000
Support 3 (S3) 23.5000 23.5000 23.5000
Support 4 (S4) 23.5000